| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4391aa1e2e87d808f0bce01b97befead |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
1997-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01917f72c3308212d0e52e5f56447641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a23c930155a880bc0b1048661993f2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0aa0dba862f870ce8e464d99de23e34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6118af03ce3d96a1f18b94c12573fc18 |
| publicationDate |
2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2260761-C |
| titleOfInvention |
Vaccine comprising antigens bound to carriers through labile bonds |
| abstract |
The invention is in the field of vaccines and immunogenic preparations. Normally in these preparations antigens and carrier compounds are irreversibly coupled in a stable bond. The invention, to the contrary, provides vaccines and immunogenic preparations in which the antigen (be it protein or peptide or carbohydrate or any other molecule to be used as an antigen for immunization/vaccination procedures) and the carrier compound are coupled in a reversible and labile way, with a so-called labile link. In this way, as is demonstrated in the experimental part of this application, surprisingly a better immune response can be elicited by an in itself poorly immunogenic antigen than by methods that provide a stable link between the antigen and carrier compound. |
| priorityDate |
1996-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |